Chen_2018_J.Enzyme.Inhib.Med.Chem_33_290

Reference

Title : Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease - Chen_2018_J.Enzyme.Inhib.Med.Chem_33_290
Author(s) : Chen Y , Zhu J , Mo J , Yang H , Jiang X , Lin H , Gu K , Pei Y , Wu L , Tan R , Hou J , Chen J , Lv Y , Bian Y , Sun H
Ref : J Enzyme Inhib Med Chem , 33 :290 , 2018
Abstract :

Small molecule cholinesterases inhibitor (ChEI) provides an effective therapeutic strategy to treat Alzheimer's disease (AD). Currently, the discovery of new ChEI with multi-target effect is still of great importance. Herein, we report the synthesis, structure-activity relationship study and biological evaluation of a series of tacrine-cinnamic acid hybrids as new ChEIs. All target compounds are evaluated for their in vitro cholinesterase inhibitory activities. The representatives which show potent activity on cholinesterase, are evaluated for the amyloid beta-protein self-aggregation inhibition and in vivo assays. The optimal compound 19, 27, and 30 (human AChE IC50 = 10.2 +/- 1.2, 16.5 +/- 1.7, and 15.3 +/- 1.8 nM, respectively) show good performance in ameliorating the scopolamine-induced cognition impairment and preliminary safety in hepatotoxicity evaluation. These compounds deserve further evaluation for the development of new therapeutic agents against AD.

PubMedSearch : Chen_2018_J.Enzyme.Inhib.Med.Chem_33_290
PubMedID: 29278947

Related information

Citations formats

Chen Y, Zhu J, Mo J, Yang H, Jiang X, Lin H, Gu K, Pei Y, Wu L, Tan R, Hou J, Chen J, Lv Y, Bian Y, Sun H (2018)
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease
J Enzyme Inhib Med Chem 33 :290

Chen Y, Zhu J, Mo J, Yang H, Jiang X, Lin H, Gu K, Pei Y, Wu L, Tan R, Hou J, Chen J, Lv Y, Bian Y, Sun H (2018)
J Enzyme Inhib Med Chem 33 :290